| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2024 , Vol 62 , Num 4
In vitro investigation of the toxicological mechanisms of gemcitabine in colorectal cancer cells
1 Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Istanbul, Türkiye, 2 Istanbul University, Institute of Graduate Studies in Health Sciences, Istanbul, Türkiye, 3 Istanbul University Cerrahpasa, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Istanbul, Türkiye
DOI :
10.23893/1307-2080.APS6256